Breaking News: Vera Therapeutics Sets the Stage for Success with Public Offering of Class A Common Stock

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its previously announced underwritten public offering of…

Read More

Innovative, Articulate, and Easy to Follow: The Premiere Synthetic Biology Event on Track for Record Attendance in 2023

SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Anticipation and excitement builds for the 2023 SynBioBeta Global Synthetic Biology Conference with global innovation network SynBioBeta announcing today event dates, keynotes, sponsors, and conference location. Set to be the largest synthetic…

Read More

Unleashing the Potential of Wearable Pulse Oximeters: Market Projected to Reach $594.5 Million by 2031 – Transparency Market Research

A Rise in Respiratory Diseases Sparks Growth in Wearable Pulse Oximeters Market Wilmington, Delaware, United States, Feb. 02, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The global Wearable Pulse Oximeters Market is likely to register a CAGR of 7.0% between 2022 and 2031. With the rise in the prevalence of respiratory diseases, the…

Read More

Interactive Brokers Sees 14% Jump in January as Client Accounts Grow: A Positive Start to the Year for Forex Traders

Interactive Brokers Reports Increase in DARTs for January 2023 Interactive Brokers, an American online broker, published its brokerage metric for January 2023 on Wednesday, reporting an increase of 14% month-over-month in its Daily Average Revenue Trades (DARTs) which reached 1.988 million. However, year-over-year (YoY) the broker’s DARTs decreased by 24% last month. Furthermore, the broker,…

Read More

Get the Scoop: OrthoPediatrics Corp’s ESG Summary Report is Here!

OrthoPediatrics Corp. Publishes Environmental, Social, and Governance (“ESG”) Summary Report WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the publication of an Environmental, Social, and Governance (“ESG”) summary report. OrthoPediatrics has long been known…

Read More

Unlocking Success: Biostem Technologies Welcomes Two New Leaders to Drive Growth – Meet Michael Sylvester, VP of Sales, and Neal Bhattacharya, VP of Marketing

BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales and Neal Bhattcharya as… POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (“BioStem” or the “Company) (OTCQB: BSEM) A New Chapter Begins for BioStem Technologies BioStem Technologies Inc., a leading regenerative medicine company specializing…

Read More